Type 1 Diabetes Trial, Recruiting NCT07304778 Sponsor: Universidad Complutense de Madrid Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07304778
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose HbA1c (a blood sugar level measured over time) is below 9%
  • People currently managing their diabetes using multiple daily injections, with both a long-acting and short-acting insulin (called MDI Bolus-Basal therapy)
  • People who wear a continuous glucose monitor (CGM) that connects to a mobile phone
  • People who are proficient in the Spanish language
  • People who are willing to take part in the trial
  • People who were diagnosed with diabetes at least one year ago
  • People who are able to use a mobile app similar to one called glUCModel
  • People who own a mobile phone running Android or iOS
  • People who are able to follow a portion-controlled diet for diabetes management
  • People who have been trained to actively manage their own insulin doses

Who may not be able to join:

  • People whose HbA1c is at or above 9% (confirm with trial site, as the source lists this under both sections)
  • People who do not wear a continuous glucose monitor (CGM)
  • People who are not proficient in Spanish
  • People diagnosed with diabetes less than one year ago
  • People who are unable to use a mobile app similar to glUCModel
  • People who are unable to follow a portion-controlled diet for diabetes
  • People who are unable to actively manage their own insulin dosing
  • People who have been diagnosed with a significant psychiatric condition
  • People currently being treated with corticosteroids (a type of medication)
  • People who have been hospitalised or had surgery in the last six months
  • People who are pregnant or planning to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34679562712

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Complutense de Madrid
Registry
ClinicalTrials.gov
Start date
11 July 2025
Est. completion
1 February 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Time in Range (TIR); Usability and adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov